TTOKKYO LIBIDO TEST 250 (250MG TESTOSTERONE UNDECANOATE/ML=10ML)
Active -Life: ORAL Less than 8 hours
Drug Class: Androgenic/Anabolic Steroid (Oral)
Average Reported Dosage: Men 240-320 mg daily (Women experienced serious VIRILIZTION)
Acne: Low except if used by androgen sensitive athletes
Water Retention: Yes, higher in dosages of 280-400mg daily
High Blood Pressure: Rare (Dosage related)
Liver Toxic: Low
DHT Conversion: Significant in higher dosage administration
Decreases HPTA functions: Low, except in higher reported dosages (above 320mg)
TTOKKYO LIBIDO TEST 250 is an injectable active testosterone. The only other orally active testosterone is methyltestosterone.
But unlike its counterpart, TTOKKYO LIBIDO TEST 250 has a unique absorption method. When ingested with or after meals it is reabsorbed through the mucosal cells in the small intestine via the lymphatic system. This ester therefore avoids absorption through the portal vein in the liver and subsequent first pass deactivation.
This means that a much higher level of TTOKKYO LIBIDO TEST 250 enters the blood stream. Some of the drug is then converted into DHT (dihydrotestosterone) which has a high affinity for androgen receptors. Due to higher DHT conversion, TTOKKYO LIBIDO TEST 250 does not aromatize (transform) into estrogen at a high rate like other testosterone.
For this reason, water retention is much lower while gyno and female pattern fat deposits are far less likely. This drug has a reported low negative effect on the HTPA (hypothalamic pituitary testes axis) and therefore does not suppress natural (endogenous) androgen production to a significant degree in the lower reported dosages.
For the most part it is due to estrogen’s negative influences that HPTA function is decreased. However, estrogen must be present in lower levels for any steroid to reach its full potential effects. Kind of a paradox huh?
When stacked with other AAS, Andriol has provided a mild androgenic/anabolic synergistic effect at dosages of 200 mg daily. However, if this drug was administered alone, this dosage did not provide much in the way of results when compared to injectable testosterone.
To rival its injectable cousins, daily dosages would need to be in the above 290-320 mg range minimum. This dosage would not only be quite expensive, it also would reach a level where suppression of the HPTA would increase a great deal due to elevated aromatization.
This also increases water retention significantly. Since TTOKKYO LIBIDO TEST 250 is quickly excreted through urine release, the drug was be taken 3-6 times daily to maintain adequate circulatory levels.
All in all TTOKKYO LIBIDO TEST 250 was reported as a mildly Androgenic / Anabolic steroid that was best used in stacks for its excellent compatibility at dosages of 240-320 mg daily.
For novice steroid users, older athletes, and safety conscience individuals, a stack of 200-240mg TTOKKYO LIBIDO TEST 250 daily, 200 mg of Primobolan depot (or 200-400 mg Anadur or Deca Durabolin) weekly, and 20 mg of Oxandrolone daily was reported to provide excellent lean mass and good strength gains with minimal suppression of the HPTA and other negative side effects.
The good news was that athletes retained the gains quite well after use was discontinued. (Unless they were highly psychologically influenced by off periods!)
THE INJECTABLE VERSION OF TESTOSTERONE UNDECOANATE RECENTLY CAME ON THE MARKET,WHAT IS INTERESTED ABOUT THIS PRODUCT,IS THAT IT HAS A HALF LIFE OF 50 DAYS,WHICH MAKE IT ONE OF THE LONGEST ACTING INJECTABLE COMPOUNDS ON THE MARKET TODAY.